triazoles has been researched along with Abdominal Migraine in 238 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 24 (10.08) | 18.2507 |
| 2000's | 173 (72.69) | 29.6817 |
| 2010's | 40 (16.81) | 24.3611 |
| 2020's | 1 (0.42) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, R; Bertelli, S; Gavazzo, P; Pusch, M | 1 |
| Amundsen, S; Fuskevåg, OM; Nordeng, H; Nordmo, E; Sager, G; Spigset, O | 1 |
| Hansen, E; Meissner, K; Zech, N | 1 |
| Crossland, DM; Dieringer, TD; Mahl, TC | 1 |
| Allais, G; Benedetto, C; Bussone, G; Omboni, S; Pezzola, D; Tullo, V; Zava, D | 1 |
| Allais, G; Barbanti, P; Benedetto, C; Bussone, G; Cortelli, P; Curone, M; Omboni, S; Peccarisi, C; Pezzola, D; Tullo, V; Zava, D | 1 |
| Evers, S | 1 |
| Alvarez-Escudero, R; Pascual, J; Ramón-Carbajo, C | 1 |
| Guidotti, M; Lisotto, C; Savi, L; Zava, D | 1 |
| Cui, XP; Lin, H; Lin, M; Mu, JS; Ye, JX | 1 |
| Burstein, R; Hoaglin, DC; Jakubowski, M; Kam-Hansen, S; Kaptchuk, TJ; Kelley, JM; Kirsch, I | 1 |
| Bingel, U | 1 |
| Egan, CG; Mogavero, S; Savi, L | 1 |
| Kitagawa, Y; Suzuki, Y; Takayanagi, R; Tokuoka, K; Watanabe, M; Yamada, Y | 1 |
| Han, X; Hao, T; Huang, Q; Yao, G; Yu, T | 1 |
| Sakai, F | 2 |
| Kushwah, A; Tomar, A | 1 |
| Bhagawati, ST; Bhat, K; Chonkar, AD; Dengale, SJ; Reddy, SM | 1 |
| Girotra, P; Singh, SK | 1 |
| Allais, G; Benedetto, C | 1 |
| Dede, HÖ; Duman, T; Şeydaoğlu, G | 1 |
| Han, W; Li, M; Wang, J; Xu, H | 1 |
| Mansbach, H; O'Quinn, S; Salonen, R | 1 |
| Diamond, M; Diamond, S; Freitag, F; Janssen, I; Rodgers, A; Skobieranda, F | 1 |
| Garg, T; Jain, S; Sharma, A; Singh, HP; Tiwary, AK | 1 |
| Hargreaves, RJ | 2 |
| Hargreaves, RJ; Ho, TW; Lines, CR; Rapoport, AM; Sheftell, FD | 1 |
| Bigal, ME; Cady, R; Hu, H; Kurth, T; Santanello, N | 1 |
| Fan, X; Ho, TW; Lines, CR; Rodgers, A; Shapiro, RE; Winner, P | 1 |
| Bigal, ME; Ho, TW; Rodgers, A | 1 |
| Bigal, M; Hu, XH; Ng-Mak, DS | 1 |
| Cady, RK; Connor, KM; Géraud, G; Ho, AP; Ho, TP; Hustad, CM; Martin, VT; Ramsey, KE; Rodgers, A; Zhang, Y | 1 |
| Evans, RW | 1 |
| Chawluk, JB | 1 |
| Jamieson, DG | 1 |
| Furman, JM; Marcus, DA | 2 |
| Bigal, ME; Cady, RK; Durham, PL; Ho, TW; Vause, CV | 1 |
| Kalita, J; Misra, UK; Yadav, RK | 3 |
| Alkhatib, AA; Gangotena, F; Peterson, KA | 1 |
| Göbel, H | 2 |
| Araki, N; Ito, Y; Kato, Y; Matsuda, H; Suzuki, C | 1 |
| Ferrari, MD; Lisotto, C; Omboni, S; Pinessi, L; Savi, L; Zanchin, G; Zava, D | 2 |
| Balaban, CD; Furman, JM; Marcus, DA | 1 |
| Cady, RK; Ho, TW; Hustad, CM; Martin, VT; Ramsey, KE; Rodgers, AJ; Winner, P | 1 |
| Ashina, M; Aurora, SK; Connor, KM; Giezek, H; Ho, TW; Jones, C; Lines, C; Loeys, T; Massaad, R; Williams-Diaz, A | 1 |
| Connor, KM; Fan, X; Friedman, D; Ge, Y; Hewitt, D; Ho, T; Hustad, CM; Lasorda, J; Newman, L; Seeburger, JL; Taylor, FR; Zhang, Y | 1 |
| Airaksinen, M; Hoppu, K; Kaukonen, AM; Klaukka, T; Lindkvist, J | 1 |
| Steiner, TJ; Tfelt-Hansen, P | 1 |
| Cady, RK; Connor, KM; Ge, Y; Ho, TW; Hustad, CM; MacGregor, A; Schaefer, E; Seeburger, JL; Strickler, N; Valade, D; Winner, P; Zhang, Y | 1 |
| Fraser, IP; Han, L; Han, TH; Hreniuk, D; Li, CC; Linder, S; Stoch, SA; Wagner, JA; Winner, P | 1 |
| Derry, CJ; Derry, S; Moore, RA | 1 |
| Aurilia, C; Barbanti, P; Bonassi, S; Dall'Armi, V; Egeo, G; Fofi, L; Vanacore, N | 1 |
| Assaid, C; Bachman, R; Connor, K; Hämäläinen, M; Hewitt, DJ; Ho, TW; Lewis, D; Lines, C; Mahoney, E; Michelson, D; Mozley, LH; Pearlman, E; Strickler, N; Zhang, Y | 1 |
| Assaid, C; Bachman, R; Ceesay, P; Connor, KM; Dupre, N; Hämäläinen, M; Harper Mozley, L; Hewitt, DJ; Ho, TW; Lewis, D; Lines, C; Mahoney, E; Michelson, D; Pearlman, E; Strickler, N | 1 |
| Casas, M; Dalmau, B; Fernandez-Atutxa, A; Gil, M; Miquel, M; Sanchez-Delgado, J; Vergara, M | 1 |
| Durham, PL; Masterson, CG | 1 |
| Rapoport, AM; Sheftell, FD; Tepper, SJ | 1 |
| Csiba, L; Ficzere, A | 1 |
| Login, IS | 1 |
| Rieder, MJ | 1 |
| Jarvis, B; Wellington, K | 1 |
| Bussone, G; D'Amico, D; Gerth, W; Lines, CR; McCarroll, KA | 1 |
| Lines, C; McCarroll, K; Tfelt-Hansen, P | 1 |
| Allen, C; Davies, G; Kramer, M; Lipton, R; Santanello, NC | 1 |
| Lines, CR; Massiou, H; McCarroll, KA; Silberstein, SD | 1 |
| Maizels, M | 1 |
| Lines, CR; McCarroll, KA; Visser, WH | 1 |
| Allen, C; Christie, S; Göbel, H; Mateos, V; Shivaprakash, M; Vrijens, F | 1 |
| López Rodríguez, I; López-Gil, A; Mateos, V; Roig, C | 1 |
| Cutrer, FM; Dayno, J; Goldstein, J; Hu, XH; Jamieson, D | 1 |
| Adelman, JU; Lewit, EJ | 1 |
| Cano Orgaz, A; Ceballos Hernansanz, MA; López-Gil, A; Sanchez Roy, R | 1 |
| John, GW; Létienne, R; Verscheure, Y | 1 |
| Gawel, M; Gladstone, JP | 1 |
| Bokish, N; Dashkovsky, E; Derazon, H; Hay, E; Hussain, A; Kafka, M; Kopelovitch, G; Nassimyan, S; Rodrig, J; Shtibelman, I | 1 |
| Grubisa, HS; Major, PW; Thie, NM | 1 |
| Baos, V; Bertral, C; Caloto, MT; Gerth, WC; Nocea, G; Serrano, A; Torrecilla, M | 1 |
| Reeder, CE; Williams, P | 1 |
| Burstein, R; Collins, B; Jakubowski, M | 1 |
| Gerth, WC; Hu, XH; Sarma, S; Silberstein, SD | 1 |
| Ashcroft, DM; Millson, D | 1 |
| Iizuka, T; Sakai, F | 1 |
| Pascual, J | 2 |
| Aijima, H; Ikemoto, F; Natsumeda, Y; Toru, T | 1 |
| Belsey, JD | 1 |
| Battisti, WP; Johnson-Pratt, L; Kolodny, A; Polis, A; Skobieranda, F | 1 |
| Bigal, ME; Krymchantowski, AV | 2 |
| Dodick, DW; Ferrari, MD; Goadsby, PJ; McCrory, DC; Williams, P | 1 |
| Tomson, T; Vetr, A; Vitols, S | 1 |
| Cady, R; Klipfel, M; Lewis, D; McCarroll, K; Nett, R; Peng, Y; Strohmaier, K; Visser, WH; Winner, P | 1 |
| Adelman, J; Cady, R; Diamond, M; Hu, XH; Martin, V; Sajjan, S | 1 |
| López-Gil, A | 1 |
| Cutrer, FM; Dodick, DW; Ferrari, MD; Goadsby, PJ; Lipton, RB; McCrory, D; Williams, P | 1 |
| Burke, TA; Laínez, MJ; Vicente-Herrero, T | 1 |
| Bigal, ME; Rapoport, AM | 2 |
| Kowa, H; Nakashima, K; Takeshima, T | 1 |
| Igarashi, H | 1 |
| Morillo, LE | 2 |
| Brucker, MJ; Carides, AD; Cutler, NR; Goldberg, MR; Jhee, SS; Kramer, MS; Majumdar, AK; Matzura-Wolfe, D; McLaughlin, D; Reines, SA | 1 |
| Muñoz, P; Pascual, J | 1 |
| Bellini, G; Bonanni, E; Gori, S; Iudice, A; Manca, L; Morelli, N; Murri, L; Orlandi, G | 1 |
| Healey, PJ; Mullins, CD; Perfetto, EM; Subedi, PR; Weis, KA | 1 |
| Capuano, A; Di Trapani, G; Evangelista, M; Ferraro, D; Mei, D; Pierguidi, L; Vollono, C | 1 |
| Hay, JW; Zhang, L | 1 |
| Lewis, DW; Sowell, M; Winner, P; Yonker, M | 1 |
| Desjardins, B; Ferko, N; Gawel, M; Grima, D; Thompson, M | 1 |
| García-Moncó, C; López-Gil, A; Pascual, J; Roig, C; Yusta Izquierdo, A | 1 |
| Foster, RH; McCormack, PL | 1 |
| Kitagawa, Y; Okuma, H; Takagi, S | 1 |
| Allais, G; Allen, C; Evers, S; Kinge, E; Láinez, MJ; Lis, K; Massaad, R; Rao, NA | 1 |
| Alberti, A; Calabresi, P; Floridi, A; Maggioni, F; Pini, LA; Rossi, C; Sarchielli, P; Zanchin, G | 1 |
| Diener, HC; Katsarava, Z; Krobot, KJ; Liedert, B; Limmroth, V; Yoon, MS | 1 |
| Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L | 1 |
| Fulton, JA; Hoffman, RS; Kahn, J; Nelson, LS | 1 |
| Billups, SJ; Carroll, N; Delate, T; Gershovich, OE; Hoffman, CK | 1 |
| Cady, R; Hustad, CM; Martin, V; Mauskop, A; Ramsey, KE; Rodgers, A; Skobieranda, F | 1 |
| Iversen, HK; Tfelt-Hansen, P | 1 |
| Bigal, ME; Filho, PF; Krymchantowski, AV | 1 |
| Barlas, S; Bell, CF; Foley, KA; Hu, XH; Solomon, G | 1 |
| Ahonen, K; Eerola, M; Hämäläinen, ML; Hoppu, K | 1 |
| Almas, M; Elkind, A; Mulhern, SA; Olson, N; Sikes, C; Sunshine, A | 1 |
| Olesen, J; Tfelt-Hansen, P | 1 |
| Adani, GL; Baccarani, U; Bresadola, F; Curro, G; Lorenzin, D | 1 |
| Acuto, G; Caiola, F; Gori, S; Iudice, A; Morelli, N; Murri, L | 1 |
| Díez, FI; Straube, A; Zanchin, G | 1 |
| Hustad, CM; Ramsey, KE; Rodgers, A; Skobieranda, F | 1 |
| Hustad, CM; Loder, E; Mannix, LK; Mueller, L; Nett, R; Ramsey, KE; Rodgers, A; Skobieranda, F | 1 |
| Chen, Y; Hu, XH; Ma, L; Ng-Mak, DS; Solomon, G | 1 |
| Cavalheiro, EA; Naffah-Mazzacoratti, Mda G; Peres, MF; Senne Soares, CA; Vieira, DS; Zukerman, E | 1 |
| McQuay, HJ; Moore, RA; Oldman, AD; Smith, LA | 2 |
| Cady, R; Hustad, C; Martin, V; Mauskop, A; Ramsey, K; Rodgers, A; Skobieranda, F | 1 |
| Gano, D; Gerretsen, P; Silver, S | 1 |
| Coluzzi, F; De Nardin, M; Facco, E; Liguori, A; Mattia, C; Petti, F; Zanette, G | 1 |
| Cady, R; Hustad, CM; Martin, V; Mauskop, A; Ramsey, KE; Rodgers, A; Seidman, LS; Skobieranda, F | 1 |
| Freitag, F; Hamid, MA; Hustad, CM; Ramsey, KE; Rodgers, A; Skobieranda, F; Taylor, FR | 1 |
| Mannix, LK | 1 |
| Ashina, M; Jensen, RH | 1 |
| Hustad, CM; Mannix, LK; Mueller, L; Nett, R; Ramsey, KE; Rodgers, A; Skobieranda, F | 1 |
| Davenport, WJ; Dodick, D; Pringsheim, T | 1 |
| Block, G; Cheng, H; Claghorn, J; Cutler, NR; Olah, TV; Panebianco, D; Reines, SA; Sramek, JJ | 1 |
| Baker, R; Cascieri, MA; Chambers, MS; Hargreaves, RJ; Haworth, K; Keown, LE; Ladduwahetty, T; MacIntyre, DE; Metzger, JM; Owen, S; Rycroft, W; Sadowski, S; Seward, EM; Shepheard, SL; Swain, CJ; Tattersall, FD; Watt, AP; Williamson, DW | 1 |
| Ferrari, MD; Jiang, K; Lines, CR; Reines, SA; Terwindt, GM; Visser, WH | 1 |
| Cheng, H; Edwards, M; Gertz, BJ; Mant, T; Olah, T; Polvino, WJ; Sciberras, DG; Stepanavage, M; Wittreich, J | 1 |
| Cumberbatch, MJ; Hargreaves, RJ; Hill, RG | 1 |
| Hargreaves, RJ; Hill, RG; Shepheard, SL; Williamson, DJ | 2 |
| Block, G; Ferrari, MD; Gijsman, H; Kramer, MS; Matzura-Wolfe, D; Polis, A; Sargent, J; Teall, J; Tuchman, M | 1 |
| Block, GA; Hartmaier, SL; Kramer, MS; Polis, AB; Santanello, NC; Silberstein, SD | 1 |
| Block, G; Cutler, N; Gross, M; Jiang, K; Reines, S; Smith, B; Teall, J; Tuchman, M; Willoughby, E | 1 |
| Steiner, TJ | 1 |
| Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR | 1 |
| Amaraneni, PG; Feighner, J; Getson, A; Kramer, MS; Matzura-Wolfe, D; McHugh, W; Polis, A; Reines, SA; Silberstein, S; Solbach, MP | 1 |
| Blum, RA; Brucker, MJ; Ermlich, SJ; Goldberg, MR; Lee, Y; McLoughlin, DA; Olah, TV; Rogers, JD; Sterrett, AT; Zhao, J | 1 |
| Block, GA; Davies, GM; Gerth, W; Lerner, D; Santanello, N | 1 |
| Ahrens, SP; Block, GA; Farmer, MV; Jiang, K; Visser, WH; Williams, DL; Willoughby, E | 1 |
| Deleu, D; Hanssens, Y | 2 |
| Allen, C; Bomhof, M; Legg, N; Patel, K; Paz, J; Vandormael, K | 1 |
| Dooley, M; Faulds, D | 1 |
| Goadsby, PJ | 2 |
| Chavez-Eng, C; Cheng, H; Ellis, JD; Geer, LA; Guiblin, AR; Halpin, RA; Liu, L; Matuszewski, BK; Rogers, JD; Varga, SL; Vyas, KP | 1 |
| Bartlett, MG; Stewart, JT; Vishwanathan, K | 1 |
| Logemann, CD; Rankin, LM | 1 |
| Leira, R; Pascual, J | 1 |
| Adelman, JU; Mannix, LK; Von Seggern, RL | 1 |
| Chernyshev, O; Gentry, P; Kailasam, J; Mathew, NT | 1 |
| Dahlof, CG; Lines, CR; Rapoport, AM; Sheftell, FD | 1 |
| Johnson-Pratt, L; Le Jeunne, C; Lines, CR; Massiou, H; McCarroll, KA; Silberstein, SD | 1 |
| Bartleson, JD | 1 |
| Allen, C; Diener, HC; Pascual, J; Patel, K; Vega, P; Vrijens, F | 1 |
| de Hoon, JN; Struijker-Boudier, HA; Troost, J; Van Bortel, LM; Willigers, JM | 1 |
| Scholz, M | 1 |
| Davies, GM; Lipton, R; Santanello, N | 1 |
| Ferrari, MD | 1 |
| Goadsby, PJ; Lipton, RB | 1 |
| Goadsby, PJ; Hargreaves, RJ | 1 |
| Saper, JR | 2 |
| Ryan, RE; Tfelt-Hansen, P | 1 |
| Silberstein, SD | 1 |
| Santanello, N; Solomon, GD | 1 |
| Dahlöf, CG; Ferrari, MD; Kramer, MS; Lines, CR; Lipton, RB; McCarroll, KA | 1 |
| Potrebic, S; Raskin, NH | 1 |
| Carides, GW; Dasbach, EJ; Gerth, WC; Pigeon, JG; Santanello, NC | 1 |
| Gawel, M; Wiebe, S | 1 |
| Göbel, H; Heinze, A; Heinze-Kuhn, K; Lindner, V | 1 |
| Allen, C; Dayno, J; Lines, C; McCarroll, K | 1 |
| Allen, C; Bussone, G; Hernandez, JF; Pascual, J; Patel, K; Vrijens, F | 1 |
| Hashimoto, S; Iwata, M | 1 |
| Ferrari, MD; Lines, CR; Loder, E; McCarroll, KA | 1 |
| Lines, CR; Malbecq, W; Vandormael, K | 1 |
| Allen, C; Cady, R; Lines, C; McCarroll, K | 1 |
| Berger, M; Frishberg, B; Hu, XH; Markson, L; Solomon, S | 1 |
| Marcus, DA | 1 |
| Ahrens, S; Cady, R; Crawford, G; Getson, A; Hairwassers, D; Lines, C; Visser, WH | 1 |
| Whitaker, JN | 1 |
| Bohidar, N; Boyle, D; Brandes, JL; Guerra, F; Johnson-Pratt, L; Kolodny, A; Loder, E; Santanello, N; Silberstein, S; Skobieranda, F; Wang, L | 1 |
| Goadsby, PJ; Jiang, K; Lines, CR; Lipton, RB; Massiou, H; McCarroll, KA; Pascual, J; Vandormael, K | 1 |
| Adelman, JU; Diener, HC; Ferrari, MD; Lines, CR; Lipton, RB; McCarroll, KA; Vandormael, K | 1 |
| Gerth, WC; Mannix, LK; McCarroll, KA; Santanello, NC; Vandormael, K; Zhang, Q | 1 |
| Lipton, RB; Newman, LC | 1 |
| Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI | 1 |
| Freitag, FG | 1 |
| Allen, C; Lines, C; McCarroll, K | 1 |
| Berger, ML; Cowan, R; Hu, XH; Markson, LE; Raskin, NH | 1 |
| Ahrens, S; Evans, JK; Jiang, K; Lewis, D; Visser, WH; Winner, P | 1 |
| Fité, B; López-Gil, A; Pascual, J | 1 |
| Plosker, GL; Wellington, K | 1 |
| Barbosa, JS; Krymchantowski, AV | 1 |
| Lines, C; Seidelin, K; Stepanavage, M; Tfelt-Hansen, P | 1 |
67 review(s) available for triazoles and Abdominal Migraine
| Article | Year |
|---|---|
[Placebo and nocebo : How can they be used or avoided?]
Topics: Analgesics; Ethics, Medical; Humans; Migraine Disorders; Nocebo Effect; Physician-Patient Relations; Placebo Effect; Placebos; Risk Factors; Triazoles; Tryptamines | 2017 |
Rizatriptan-Induced Colonic Ischemia: A Case Report and Literature Review.
Topics: Colectomy; Colonic Diseases; Computed Tomography Angiography; Humans; Infarction; Male; Mesenteric Ischemia; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2018 |
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.
Topics: Carbazoles; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Migraine Disorders; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2013 |
The efficacy of triptans in childhood and adolescence migraine.
Topics: Adolescent; Analgesics; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Germany; Humans; Male; Migraine Disorders; Oxazolidinones; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2013 |
[Rizatriptan: experience after 15 years of clinical use].
Topics: Adolescent; Adult; Biological Availability; Child; Clinical Trials as Topic; Drug Approval; Humans; Migraine Disorders; Patient Acceptance of Health Care; Serotonin; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 2013 |
Efficacy, safety, and tolerability of telcagepant in the treatment of acute migraine: a meta-analysis.
Topics: Acute Disease; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Humans; Imidazoles; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2015 |
Oral triptans in children and adolescents: an update.
Topics: Acetaminophen; Administration, Oral; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Tryptamines; United States; United States Food and Drug Administration | 2015 |
Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Italy; Ketoprofen; Male; Migraine Disorders; Randomized Controlled Trials as Topic; Triazoles; Tromethamine; Tryptamines | 2016 |
Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Pyrrolidines; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2016 |
Ten years of rizatriptan: from development to clinical science and future directions.
Topics: Animals; Drug Design; Drug Evaluation; Drug Therapy; History, 20th Century; History, 21st Century; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2009 |
Acute migraine treatment with rizatriptan in real world settings - focusing on treatment strategy, effectiveness, and behavior.
Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Outcome Assessment, Health Care; Patient Selection; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2009 |
Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis.
Topics: Double-Blind Method; Evidence-Based Medicine; Humans; Meta-Analysis as Topic; Migraine Disorders; Patient Preference; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2010 |
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study database.
Topics: Adult; Clinical Trials, Phase III as Topic; Databases, Factual; Endpoint Determination; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; United States; United States Food and Drug Administration | 2011 |
Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.
Topics: Acute Disease; Administration, Intranasal; Adult; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pain Management; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2012 |
Mechanisms of action of the 5-HT1B/1D receptor agonists.
Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2002 |
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2002 |
Spotlight on rizatriptan in migraine.
Topics: Animals; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2002 |
Rizatriptan: pharmacological differences from sumatriptan and clinical results.
Topics: Administration, Oral; Humans; Migraine Disorders; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Comparative aspects of triptans in treating migraine.
Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Newer formulations of the triptans: advances in migraine management.
Topics: Analgesics; Area Under Curve; Chemistry, Pharmaceutical; Humans; Migraine Disorders; Oxazolidinones; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2003 |
Triptans for treatment of acute pediatric migraine: a systematic literature review.
Topics: Acute Disease; Administration, Intranasal; Administration, Oral; Child; Clinical Trials as Topic; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
Topics: Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2004 |
[Recent progress in therapy for migraine headache].
Topics: Anticonvulsants; Botulinum Toxins; Calcitonin Gene-Related Peptide; Central Nervous System; Clinical Trials as Topic; Drug Design; Fructose; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Pain; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Signal Transduction; Sumatriptan; Topiramate; Triazoles; Trigeminal Nerve; Tryptamines; Vasodilation | 2004 |
A review of rizatriptan, a quick and consistent 5-HT1B/1D agonist for the acute treatment of migraine.
Topics: Acute Disease; Administration, Oral; Clinical Trials as Topic; Drug Interactions; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Triazoles; Tryptamines | 2004 |
[Rizatriptan (Maxalt), a new entity of triptan for migraine: pharmacology and therapeutic relevance].
Topics: Clinical Trials as Topic; Humans; Meningeal Arteries; Migraine Disorders; Quality of Life; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Serotonin 5-HT1 Receptor Agonists; Tablets; Triazoles; Trigeminal Nerve; Tryptamines | 2004 |
Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials.
Topics: Administration, Oral; Analysis of Variance; Cost-Benefit Analysis; Drug Costs; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles | 2004 |
Preventive migraine therapy: what is new.
Topics: Analgesics; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Second-Generation; Antioxidants; Benzimidazoles; Biphenyl Compounds; Botulinum Toxins; Clonidine; Coenzymes; Fructose; Humans; Lisinopril; Migraine Disorders; Neuroprotective Agents; Petasites; Phytotherapy; Piperazines; Tetrazoles; Topiramate; Triazoles; Ubiquinone | 2004 |
[Meta-analysis of triptan treatment in migraine].
Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2004 |
[Side effects of triptans].
Topics: Central Nervous System; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sleep Stages; Sumatriptan; Triazoles; Tryptamines; Vomiting | 2004 |
Migraine headache.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Drug Therapy, Combination; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
Migraine headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Sumatriptan; Triazoles; Tryptamines | 2004 |
Migraine preventive therapy: current and emerging treatment options.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Calcium Channel Blockers; Coenzymes; Drug Therapy; Humans; Levetiracetam; Lisinopril; Migraine Disorders; Petasites; Piperazines; Piracetam; Preventive Medicine; Triazoles; Ubiquinone | 2005 |
Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
Topics: Caffeine; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Economics, Pharmaceutical; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2005 |
The treatment of pediatric migraine.
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Antidepressive Agents; Antiemetics; Biofeedback, Psychology; Calcium Channel Blockers; Child; Complementary Therapies; Contraindications; Cyproheptadine; Diet; Ergot Alkaloids; Humans; Migraine Disorders; Migraine without Aura; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2005 |
Rizatriptan in migraine.
Topics: Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Expert Testimony; Humans; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2005 |
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
Topics: Economics, Pharmaceutical; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2005 |
[Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
Topics: Acute Disease; Administration, Oral; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2006 |
WITHDRAWN: Rizatriptan for acute migraine.
Topics: Acute Disease; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2007 |
Acute treatment of paediatric migraine: a meta-analysis of efficacy.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Dihydroergotamine; Drug Evaluation; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2008 |
A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future.
Topics: Adult; Child; Drug Therapy, Combination; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2008 |
Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Double-Blind Method; Estrogens; Evidence-Based Medicine; Female; Humans; Male; Mefenamic Acid; Menstruation; Meta-Analysis as Topic; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2008 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 1999 |
Rizatriptan: a review of its efficacy in the management of migraine.
Topics: Administration, Oral; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines | 1999 |
The scientific basis of medication choice in symptomatic migraine treatment.
Topics: Acute Disease; Choice Behavior; Dose-Response Relationship, Drug; Humans; Indoles; Migraine Disorders; Models, Biological; Oxazoles; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Triazoles; Tryptamines | 1999 |
Newer intranasal migraine medications.
Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2000 |
[Rizatriptan].
Topics: Dose-Response Relationship, Drug; Drug Tolerance; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
Topics: Acute Disease; Carbazoles; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Rizatriptan in the treatment of migraine.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Safety; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1999 |
Pharmacology and potential mechanisms of action of rizatriptan.
Topics: Brain; Humans; Migraine Disorders; Muscle, Smooth, Vascular; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Synaptic Transmission; Triazoles; Trigeminal Nerve; Tryptamines | 2000 |
Rizatriptan in acute treatment of migraine: update on new comparative data.
Topics: Acute Disease; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2000 |
Safety and tolerability of rizatriptan.
Topics: Adverse Drug Reaction Reporting Systems; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
The use of rizatriptan in the treatment of acute, multiple migraine attacks.
Topics: Acute Disease; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Impact of migraine and migraine therapy on productivity and quality of life.
Topics: Humans; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Surveys and Questionnaires; Triazoles; Tryptamines | 2000 |
New abortive agents for the treatment of migraine.
Topics: Clinical Trials as Topic; Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prognosis; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Evidence-based analysis of a migraine treatment drug comparison trial.
Topics: Adult; Clinical Trials as Topic; Evidence-Based Medicine; Female; Humans; Migraine Disorders; Sumatriptan; Triazoles; Tryptamines | 2000 |
[Current topics: expectation for new triptans].
Topics: Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.
Topics: Adult; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2001 |
What matters is not the differences between triptans, but the differences between patients.
Topics: Humans; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Triptans for migraine headache: therapeutic progress meets a heterogeneous patient response.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles | 2001 |
Comparison of rizatriptan and other triptans on stringent measures of efficacy.
Topics: Administration, Oral; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Rizatriptan for acute migraine.
Topics: Acute Disease; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2001 |
Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
Topics: Adolescent; Adult; Aged; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Acute treatment of migraine and the role of triptans.
Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Rizatriptan: an update of its use in the management of migraine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Biological Availability; Databases, Bibliographic; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2002 |
78 trial(s) available for triazoles and Abdominal Migraine
| Article | Year |
|---|---|
Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.
Topics: Adult; Analgesics; Carbazoles; Cost-Benefit Analysis; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Triazoles; Tryptamines | 2013 |
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
Topics: Drug Labeling; Endpoint Determination; Humans; Migraine Disorders; Pain Measurement; Placebos; Treatment Outcome; Triazoles; Tryptamines | 2014 |
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
Topics: Adult; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Migraine Disorders; Pilot Projects; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2014 |
Theory-based analysis of clinical efficacy of triptans using receptor occupancy.
Topics: Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2014 |
Clinicopharmacological comparative study of rizatriptan versus conventional therapy in migraine.
Topics: Acetaminophen; Adolescent; Adult; Aged; Alprazolam; Analgesics, Non-Narcotic; Female; Flunarizine; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents; Young Adult | 2014 |
[Comparison of triptans, NSAID and combination in migraine attack treatment].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Female; Humans; Male; Migraine Disorders; Pain Measurement; Piroxicam; Serotonin Antagonists; Treatment Outcome; Triazoles; Tryptamines | 2016 |
Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
Topics: Acetaminophen; Acute Disease; Adult; Aged; Analgesics, Non-Narcotic; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; United States | 2008 |
Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Migraine Disorders; Opioid-Related Disorders; Pain Measurement; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2009 |
Migraine treatment with rizatriptan and almotriptan: a crossover study.
Topics: Adult; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Proportional Hazards Models; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2009 |
Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Early Diagnosis; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Education as Topic; Placebo Effect; Self-Assessment; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2009 |
A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.
Topics: Adult; Double-Blind Method; Female; Humans; Migraine Disorders; Motion Sickness; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2009 |
Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
Topics: Acute Disease; Adult; Biomarkers; Calcitonin Gene-Related Peptide; Drug Resistance; Female; Humans; Male; Middle Aged; Migraine Disorders; Predictive Value of Tests; Saliva; Salivary Glands; Sensitivity and Specificity; Serotonin Receptor Agonists; Triazoles; Tryptamines; Up-Regulation; Young Adult | 2009 |
A comparison of migraine patients with and without allodynic symptoms.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Double-Blind Method; Female; Humans; Ibuprofen; Male; Middle Aged; Migraine Disorders; Pain; Pain Measurement; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult | 2009 |
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.
Topics: Adolescent; Adult; Aged; Carbazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; Italy; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult | 2011 |
Rizatriptan reduces vestibular-induced motion sickness in migraineurs.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Motion Sickness; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vestibular Diseases; Young Adult | 2011 |
Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.
Topics: Adult; Aged; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Endpoint Determination; Female; Humans; Imidazoles; Male; Middle Aged; Migraine Disorders; Triazoles; Tryptamines | 2011 |
Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Young Adult | 2011 |
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
Topics: Acute Disease; Adolescent; Adult; Aged; Carbazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Italy; Menstruation Disturbances; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult | 2011 |
Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Disability Evaluation; Double-Blind Method; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Neuroprotective Agents; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Topiramate; Treatment Outcome; Triazoles; Tryptamines; Young Adult | 2012 |
Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.
Topics: Adolescent; Child; Double-Blind Method; Female; Headache; Humans; Male; Migraine Disorders; Triazoles; Tryptamines | 2012 |
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.
Topics: Adult; Autonomic Nervous System Diseases; Chi-Square Distribution; Double-Blind Method; Female; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Physical Examination; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2012 |
Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.
Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2012 |
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs.
Topics: Adolescent; Child; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2013 |
Determinants of migraine-specific quality of life.
Topics: Adult; Humans; Migraine Disorders; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2002 |
Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
Topics: Adolescent; Adult; Aged; Caffeine; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2003 |
[Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Patient Satisfaction; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2002 |
Real-world experiences in migraine therapy with rizatriptan.
Topics: Acute Disease; Adult; Female; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines; United States | 2003 |
Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness.
Topics: Adolescent; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Ergot Alkaloids; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Prospective Studies; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Triazoles; Tryptamines | 2003 |
Rizatriptan RPD for severe migraine in the emergency department--a multicenter study.
Topics: Adult; Emergency Medical Services; Female; Humans; Male; Middle Aged; Migraine Disorders; Treatment Outcome; Triazoles; Tryptamines | 2003 |
Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Female; Humans; Male; Middle Aged; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2003 |
Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Sumatriptan; Tablets; Triazoles; Tryptamines | 2004 |
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; ortho-Aminobenzoates; Secondary Prevention; Serotonin Receptor Agonists; Sulfones; Treatment Outcome; Triazoles; Tryptamines | 2004 |
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Topics: Acute Disease; Adolescent; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2004 |
Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pharmacies; Prospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2004 |
Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 1999 |
Rizatriptan does not change cerebral blood flow velocity during migraine attacks.
Topics: Adult; Cerebral Cortex; Female; Functional Laterality; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Middle Cerebral Artery; Migraine Disorders; Regional Blood Flow; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2005 |
Multiple attack study on the available triptans in Italy versus placebo.
Topics: Adult; Female; Humans; Indoles; Italy; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2005 |
Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Prospective Studies; Recovery of Function; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2005 |
Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Motion Sickness; Placebos; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2006 |
Clinical efficacy of rizatriptan for patients with migraine: efficacy of drug therapy for migraine accompanied by tension headache-like symptoms, focusing on neck stiffness.
Topics: Adult; Female; Humans; Male; Migraine Disorders; Muscular Diseases; Neck Muscles; Serotonin Receptor Agonists; Tension-Type Headache; Triazoles; Tryptamines | 2005 |
Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Serotonin Receptor Agonists; Tablets; Time Factors; Triazoles; Tryptamines | 2006 |
Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
Topics: Acute Disease; Adult; Female; Humans; Male; Medical Records; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Triazoles; Tryptamines | 2006 |
Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
Topics: Acute Disease; Adolescent; Adult; Aged; Drug Combinations; Female; Gastrointestinal Agents; Gastroparesis; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Placebo Effect; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Trimebutine; Tryptamines | 2006 |
Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Topics: Adult; Cross-Over Studies; Female; Humans; Male; Migraine Disorders; Prospective Studies; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2006 |
A randomized trial of rizatriptan in migraine attacks in children.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Child; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Finland; Humans; Male; Migraine Disorders; Placebo Effect; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2006 |
Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
Topics: Adult; Analysis of Variance; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pilot Projects; Pyrrolidines; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2006 |
Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Single-Blind Method; Time Factors; Triazoles; Tryptamines | 2007 |
Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Comorbidity; Double-Blind Method; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Ohio; Pain Measurement; Placebo Effect; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2007 |
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Ibuprofen; Male; Migraine Disorders; Sample Size; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2007 |
Symptoms of cutaneous sensitivity pre-treatment and post-treatment: results from the rizatriptan TAME studies.
Topics: Adult; Comorbidity; Double-Blind Method; Female; Headache; Humans; Hyperalgesia; Male; Migraine Disorders; Placebo Effect; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Serotonin Receptor Agonists; Touch; Treatment Outcome; Triazoles; Tryptamines; United States | 2007 |
Traditional acupuncture in migraine: a controlled, randomized study.
Topics: Acupuncture Therapy; Adult; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Migraine Disorders; Placebos; Serotonin Receptor Agonists; Single-Blind Method; Triazoles; Tryptamines | 2008 |
Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies.
Topics: Adult; Disability Evaluation; Double-Blind Method; Drug Evaluation; Female; Humans; Menstruation Disturbances; Migraine Disorders; Pain Measurement; Prospective Studies; Retrospective Studies; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2008 |
Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Nausea; Placebos; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2008 |
Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine.
Topics: Adolescent; Adult; Clinical Protocols; Disability Evaluation; Double-Blind Method; Female; Humans; Menstruation Disturbances; Migraine Disorders; Pain Measurement; Prospective Studies; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Young Adult | 2008 |
Pilot study of MK-462 in migraine.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Pilot Projects; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1996 |
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 1996 |
Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist.
Topics: Administration, Oral; Adult; Analysis of Variance; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 1997 |
Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine.
Topics: Acute Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Migraine Disorders; Regression Analysis; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1997 |
Improvement in migraine-specific quality of life in a clinical trial of rizatriptan.
Topics: Adult; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Quality of Life; Reproducibility of Results; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Triazoles; Tryptamines | 1997 |
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1998 |
A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 1998 |
Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Dizziness; Female; Humans; Injections, Intravenous; Migraine Disorders; Serotonin Receptor Agonists; Tachycardia; Triazoles; Tryptamines | 1998 |
Validation of a migraine work and productivity loss questionnaire for use in migraine studies.
Topics: Absenteeism; Adult; Disability Evaluation; Female; Humans; Male; Middle Aged; Migraine Disorders; Reproducibility of Results; Serotonin Receptor Agonists; Sickness Impact Profile; Triazoles; Tryptamines | 1999 |
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dosage Forms; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 1999 |
Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Piperidines; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 1999 |
Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
Topics: Administration, Oral; Cross-Over Studies; Drug Resistance; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Retreatment; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2000 |
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.
Topics: Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Oxazolidinones; Quality of Life; Recurrence; Retreatment; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2000 |
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches.
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carotid Artery, Common; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Sumatriptan; Temporal Arteries; Triazoles; Tryptamines; Ultrasonography; Vascular Resistance; Vasoconstrictor Agents; Vasodilation | 2000 |
Within-patient consistency of response of rizatriptan for treating migraine.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Triazoles; Tryptamines | 2000 |
Work and productivity loss in the rizatriptan multiple attack study.
Topics: Absenteeism; Adult; Efficiency; Female; Humans; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Surveys and Questionnaires; Triazoles; Tryptamines; Work | 2000 |
Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes.
Topics: Adult; Female; Humans; Male; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan; Tablets; Triazoles; Tryptamines | 2001 |
A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Serotonin Agents; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 2001 |
Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Pain Measurement; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
Topics: Adult; Cross-Over Studies; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tablets; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 2001 |
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Placebos; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2002 |
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Female; Humans; Lactones; Male; Middle Aged; Migraine Disorders; Nausea; Pilot Projects; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sulfones; Triazoles; Tryptamines | 2002 |
The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.
Topics: Adult; Arteries; Cross-Over Studies; Double-Blind Method; Drug Combinations; Ergotamine; Heart Rate; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2002 |
93 other study(ies) available for triazoles and Abdominal Migraine
| Article | Year |
|---|---|
Late sodium current blocker GS967 inhibits persistent currents induced by familial hemiplegic migraine type 3 mutations of the SCN1A gene.
Topics: Action Potentials; Epilepsy; HEK293 Cells; Humans; Migraine Disorders; Migraine with Aura; Mutation; NAV1.1 Voltage-Gated Sodium Channel; Neurons; Pyridines; Sodium; Triazoles | 2019 |
Transfer of triptans into human breast milk and estimation of infant drug exposure through breastfeeding.
Topics: Adult; Breast Feeding; Female; Humans; Infant; Infant, Newborn; Migraine Disorders; Milk, Human; Oxazolidinones; Piperidines; Pyrrolidines; Triazoles; Tryptamines | 2021 |
Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.
Topics: Carbazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Double-Blind Method; Female; Humans; Menstruation; Migraine Disorders; Multicenter Studies as Topic; Oxazolidinones; Premenstrual Syndrome; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2013 |
[Expectation is one half of therapy].
Topics: Analgesics; Culture; Humans; Migraine Disorders; Placebo Effect; Randomized Controlled Trials as Topic; Triazoles; Tryptamines | 2014 |
Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model.
Topics: Animals; Calcitonin Gene-Related Peptide; Cholecystokinin; Female; Male; Migraine Disorders; Periaqueductal Gray; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; RNA, Messenger; Serotonin 5-HT1 Receptor Agonists; Triazoles; Tryptamines | 2015 |
Bioavailability Enhancement of Rizatriptan Benzoate by Oral Disintegrating Strip: In vitro and In vivo Evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Drug Delivery Systems; Drug Liberation; Drug Stability; Female; Male; Migraine Disorders; Mouth Mucosa; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Sheep; Solubility; Tablets; Tensile Strength; Triazoles; Tryptamines | 2016 |
Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Topics: Administration, Oral; Animals; Brain; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Lipids; Male; Mice; Migraine Disorders; Nanoparticles; Particle Size; Rats; Rats, Wistar; Surface-Active Agents; Triazoles; Tryptamines | 2017 |
Comparison of rizatriptan and sumatriptan.
Topics: Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Vasoconstrictor Agents | 1999 |
Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation.
Topics: Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Elasticity; Hyperalgesia; Liposomes; Male; Mice; Microscopy, Electron, Scanning; Migraine Disorders; Rats; Rats, Wistar; Skin; Solubility; Triazoles; Tryptamines | 2008 |
10 years of rizatriptan.
Topics: History, 20th Century; History, 21st Century; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2009 |
Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults.
Topics: Adolescent; Adult; Age Factors; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebo Effect; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines; Young Adult | 2009 |
[Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks].
Topics: Administration, Sublingual; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Costs; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2009 |
Rizatriptan. Convenience and consistency.
Topics: Acute Disease; Administration, Oral; Humans; Migraine Disorders; Serotonin Receptor Agonists; Tablets; Triazoles; Tryptamines | 2000 |
Evaluating the efficacy of migraine therapy.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 2000 |
Rizatriptan. Comparative trial results.
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents; Young Adult | 2000 |
A study of triggers of migraine in India.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diet; Disability Evaluation; Eating; Female; Humans; Ibuprofen; India; Male; Middle Aged; Migraine Disorders; Pain Measurement; Physical Exertion; Prognosis; Prospective Studies; Serotonin Receptor Agonists; Sleep Deprivation; Stress, Psychological; Triazoles; Tryptamines; Weather; Young Adult | 2010 |
Rizatriptan induced acute on top of chronic ischemic colitis.
Topics: Colitis, Ischemic; Colonoscopy; Diagnosis, Differential; Female; Humans; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2009 |
Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan.
Topics: Adult; Cerebral Arteries; Cerebrovascular Circulation; Cerebrovascular Disorders; Functional Laterality; Humans; Hyperemia; Hypothalamus; Magnetic Resonance Imaging; Male; Migraine Disorders; Prefrontal Cortex; Serotonin Receptor Agonists; Thalamus; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2010 |
Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007.
Topics: Adolescent; Adult; Age Factors; Child; Drug Approval; Female; Finland; Humans; Male; Migraine Disorders; Off-Label Use; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Young Adult | 2011 |
Suggested randomised, controlled trial with frovatriptan.
Topics: Carbazoles; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2011 |
[Rizatriptan-induced liver toxicity. Report of a case].
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Female; Humans; Immune Complex Diseases; Jaundice, Obstructive; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2013 |
Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
Topics: Analgesics; Animals; Blotting, Western; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Cells, Cultured; Immunohistochemistry; Migraine Disorders; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Triazoles; Trigeminal Ganglion; Tryptamines | 2013 |
Comparison of rizatriptan and other triptans on stringent measures of efficacy.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2002 |
Comparison of rizatriptan and other triptans on stringent measures of efficacy.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2002 |
Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2002 |
Sum of Pain Intensity Differences (SPID) in migraine trials. A comment based on four rizatriptan trials.
Topics: Humans; Migraine Disorders; Outcome Assessment, Health Care; Pain Measurement; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2002 |
Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
Topics: Administration, Oral; Adult; Female; Humans; Menstruation; Migraine Disorders; Retrospective Studies; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2002 |
Rizatriptan 5mg is not efficacious for migraine in adolescents.
Topics: Acute Disease; Adolescent; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2002 |
[New onset headache. Which patients should be sent for CT imaging?].
Topics: Acute Disease; Brain Diseases; Diagnosis, Differential; Drug Administration Schedule; Headache; Humans; Migraine Disorders; Tomography, X-Ray Computed; Triazoles; Tryptamines | 2002 |
[New therapeutic recommendations for severe migraine. High beginning dosage rather than slow dosage increase].
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2003 |
Investigation of the effects of naratriptan, rizatriptan, and sumatriptan on jugular venous oxygen saturation in anesthetized pigs: implications for their mechanism of acute antimigraine action.
Topics: Anesthesia; Animals; Blood Gas Analysis; Hemodynamics; Indoles; Jugular Veins; Male; Migraine Disorders; Oxygen; Piperidines; Sumatriptan; Swine; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2003 |
[Highly selective beginning. Associated symptoms and side effects in retrospect].
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
Topics: Acute Disease; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Care Costs; Health Services; Humans; Indoles; Male; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2003 |
Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
Topics: Administration, Oral; Adolescent; Adult; Humans; Injections; Middle Aged; Migraine Disorders; Oxazolidinones; Pain; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Skin; Sumatriptan; Time Factors; Triazoles; Tryptamines | 2004 |
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
Topics: Absenteeism; Adult; Cost-Benefit Analysis; Efficiency; Employer Health Costs; Female; Humans; Male; Middle Aged; Migraine Disorders; Models, Economic; Serotonin Receptor Agonists; Triazoles; Tryptamines; United States; Workplace | 2004 |
[It impairs quality of life and work time. Migraine therapy should not be left to the patients!].
Topics: Absenteeism; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Ergot Alkaloids; Germany; Humans; Migraine Disorders; Occupational Diseases; Quality of Life; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2003 |
TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
Topics: Administration, Oral; Adult; Data Collection; Decision Support Techniques; Dose-Response Relationship, Drug; Female; Humans; Indoles; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Patient Selection; Pyrrolidines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2004 |
[It's possible to influence prescriptions patterns by producer-independent information].
Topics: Community Health Centers; Drug Information Services; Drug Prescriptions; Follow-Up Studies; Guideline Adherence; Humans; Migraine Disorders; Pharmacology, Clinical; Physicians, Family; Practice Guidelines as Topic; Practice Patterns, Physicians'; Serotonin Receptor Agonists; Sweden; Triazoles; Tryptamines | 2004 |
Evaluating triptan usage: a rebuttal.
Topics: Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2004 |
[Modern migraine therapy].
Topics: Absenteeism; Adult; Cross-Sectional Studies; Drug Utilization; Female; Germany; Humans; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2004 |
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
Topics: Acute Disease; Administration, Oral; Adult; Data Collection; Decision Support Techniques; Dose-Response Relationship, Drug; Female; Humans; Indoles; Male; Meta-Analysis as Topic; Migraine Disorders; Physicians, Family; Practice Patterns, Physicians'; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Sulfonamides; Triazoles; United States | 2004 |
The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Topics: Absenteeism; Adult; Costs and Cost Analysis; Counseling; Efficiency; Female; Follow-Up Studies; Humans; Male; Migraine Disorders; Occupational Health Services; Postal Service; Serotonin Receptor Agonists; Spain; Triazoles; Tryptamines | 2004 |
Correlation between lipophilicity and triptan outcomes.
Topics: Central Nervous System Diseases; Chemical Phenomena; Chemistry, Physical; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Serotonin Receptor Agonists; Statistics as Topic; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2005 |
[Migraine therapy--rapid and effective].
Topics: Clinical Trials as Topic; Drug Administration Schedule; Humans; Migraine Disorders; Secondary Prevention; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2004 |
[Migraine].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Child; Female; Humans; Internet; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2004 |
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
Topics: Algorithms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Humans; Managed Care Programs; Migraine Disorders; Piperidines; Pyrrolidines; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2005 |
An economic evaluation of rizatriptan in the treatment of migraine.
Topics: Canada; Cost-Benefit Analysis; Decision Trees; Humans; Migraine Disorders; Reproducibility of Results; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2005 |
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
Topics: Calcitonin Gene-Related Peptide; Drug Resistance; Humans; Immunoenzyme Techniques; Migraine Disorders; Neurokinin A; Serotonin Receptor Agonists; Triazoles; Tryptamines; Vasoactive Intestinal Peptide | 2006 |
Company reference estimates for productivity loss due to migraine and productivity gains using rizatriptan 10 mg in Germany.
Topics: Absenteeism; Adult; Aged; Cost of Illness; Efficiency; Female; Germany; Humans; Male; Middle Aged; Migraine Disorders; Prevalence; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2006 |
[Medical treatment of migraine attacks in the child].
Topics: Acetaminophen; Age Factors; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Ergot Alkaloids; Humans; Ibuprofen; Life Style; Migraine Disorders; Oxazolidinones; Parents; Patient Education as Topic; Pediatrics; Piperidines; Pyrrolidines; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Taste Disorders; Triazoles; Tryptamines; Vasoconstrictor Agents | 2006 |
Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.
Topics: Adult; Cluster Headache; Humans; Infarction; Kidney; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Serotonin Receptor Agonists; Tomography, X-Ray Computed; Triazoles; Tryptamines | 2006 |
Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
Topics: Female; Health Maintenance Organizations; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Migraine Disorders; Patient Satisfaction; Primary Health Care; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Surveys and Questionnaires; Treatment Outcome; Triazoles; Tryptamines | 2006 |
Increasing the effect of triptans in migraine.
Topics: Cross-Over Studies; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Triazoles; Trimebutine; Tryptamines | 2006 |
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: a case report.
Topics: Adult; Humans; Ischemic Attack, Transient; Liver Transplantation; Male; Migraine Disorders; Postoperative Complications; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2006 |
A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
Topics: Administration, Oral; Cost-Benefit Analysis; Decision Trees; Humans; Italy; Migraine Disorders; Sensitivity and Specificity; Triazoles; Tryptamines | 2006 |
Comment on eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
Topics: Humans; Migraine Disorders; Patient Satisfaction; Pyrrolidines; Retreatment; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2007 |
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
Topics: Acute Disease; Adult; Cross-Over Studies; Female; Humans; Male; Middle Aged; Migraine Disorders; Multivariate Analysis; Patient Satisfaction; Prospective Studies; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2007 |
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Glutamic Acid; Headache Disorders; Headache Disorders, Secondary; Humans; Male; Middle Aged; Migraine Disorders; Piperidines; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2007 |
[Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].
Topics: Clinical Trials as Topic; Cross-Over Studies; Drug and Narcotic Control; Germany; Humans; Migraine Disorders; Multicenter Studies as Topic; Patient Satisfaction; Practice Guidelines as Topic; Prospective Studies; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines; Vasoconstrictor Agents | 2007 |
[A new therapeutic principle for migraine].
Topics: Azepines; Calcitonin Gene-Related Peptide; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents | 2008 |
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists.
Topics: Animals; Biological Availability; Drug Stability; Ferrets; Guinea Pigs; Humans; Inflammation; Macaca mulatta; Male; Microsomes, Liver; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Piperidines; Rats; Receptors, Neurokinin-1; Triazoles; Vomiting | 1996 |
Rizatriptan has central antinociceptive effects against durally evoked responses.
Topics: Action Potentials; Analysis of Variance; Animals; Blood-Brain Barrier; Disease Models, Animal; Dose-Response Relationship, Drug; Dura Mater; Electric Stimulation; Electrophysiology; Injections, Intravenous; Male; Microelectrodes; Migraine Disorders; Neurons; Pain; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Triazoles; Trigeminal Caudal Nucleus; Tryptamines | 1997 |
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
Topics: Analysis of Variance; Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dura Mater; Electric Stimulation; Injections, Intravenous; Lethal Dose 50; Male; Meningeal Arteries; Migraine Disorders; Neuromuscular Junction; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance P; Triazoles; Trigeminal Nuclei; Tryptamines; Vasodilation | 1997 |
Please don't hi-jack "quality of life".
Topics: Humans; Migraine Disorders; Quality of Life; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1998 |
Coronary side-effect potential of current and prospective antimigraine drugs.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 1998 |
Oral migraine drug approved for marketing.
Topics: Administration, Oral; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
Topics: Administration, Oral; Area Under Curve; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cross-Over Studies; Feces; Humans; Infusions, Intravenous; Male; Migraine Disorders; Reference Values; Serotonin Receptor Agonists; Tissue Distribution; Triazoles; Tryptamines | 2000 |
Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry.
Topics: Bufotenin; Chromatography, High Pressure Liquid; Humans; Indoles; Mass Spectrometry; Migraine Disorders; Molecular Structure; Oxazoles; Oxazolidinones; Piperidines; Sensitivity and Specificity; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2000 |
Rizatriptan tablet versus wafer: patient preference.
Topics: Adult; Dosage Forms; Drug Evaluation; Freeze Drying; Humans; Migraine Disorders; Patient Satisfaction; Retrospective Studies; Serotonin Receptor Agonists; Tablets; Triazoles; Tryptamines | 2000 |
Rizatriptan in the treatment of menstrual migraine.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Odds Ratio; Randomized Controlled Trials as Topic; Retrospective Studies; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; United States | 2000 |
Triptans to the rescue: effective therapy for migraine headaches in the workplace.
Topics: Absenteeism; Adult; Cost-Benefit Analysis; Efficiency; Female; Humans; Indoles; Injections, Subcutaneous; Male; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Self Administration; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Workplace | 2000 |
Treatment options for acute migraine.
Topics: Acute Disease; Adult; Female; Humans; Migraine Disorders; Oxazolidinones; Patient Selection; Practice Guidelines as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2000 |
Determinants of patient satisfaction with migraine therapy.
Topics: Adult; Analgesics; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Patient Satisfaction; Photophobia; Placebos; Randomized Controlled Trials as Topic; Severity of Illness Index; Single-Blind Method; Time Factors; Triazoles; Tryptamines; Vomiting; White People | 2000 |
Rizatriptan: a new milestone in migraine treatment. Introduction.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2000 |
Rizatriptan: a new milestone in migraine treatment. Closing remarks.
Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Newer triptans: emphasis on rizatriptan.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2000 |
Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines | 2000 |
Rizatriptan versus usual care in long-term treatment of migraine.
Topics: Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Triazoles; Tryptamines | 2000 |
[Migraine therapy. Help for the head--without risk for to the heart].
Topics: Hemodynamics; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2000 |
Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine.
Topics: Administration, Sublingual; Humans; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines | 2001 |
Effect of rizatriptan in the spectrum of headache.
Topics: Clinical Trials as Topic; Humans; Migraine Disorders; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Tension-Type Headache; Triazoles; Tryptamines | 2001 |
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
Topics: Activities of Daily Living; Adult; Female; Humans; Male; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Surveys and Questionnaires; Tablets; Treatment Outcome; Triazoles; Tryptamines | 2001 |
The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
Topics: Anesthesia; Animals; Benzamides; Calcitonin Gene-Related Peptide; Chromans; Dose-Response Relationship, Drug; Dura Mater; Guinea Pigs; Humans; Indoles; Male; Meningeal Arteries; Migraine Disorders; Peptide Fragments; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Triazoles; Tryptamines; Vasodilation | 2001 |
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Topics: Administration, Oral; Adult; Double-Blind Method; Humans; Indoles; Migraine Disorders; Nausea; Oxazolidinones; Piperidines; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2001 |
Migraine MLT-down: an unusual presentation of migraine in patients with aspartame-triggered headaches.
Topics: Adolescent; Adult; Aspartame; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Sweetening Agents; Triazoles; Tryptamines | 2001 |
[Therapy of an acute migraine attack. Uniform patient vote for rizatriptan].
Topics: Germany; Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Evidence-based migraine therapy.
Topics: Evidence-Based Medicine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Treatment of migraine with rizatriptan: when to take the medication.
Topics: Drug Administration Schedule; Humans; Migraine Disorders; Prospective Studies; Serotonin Receptor Agonists; Severity of Illness Index; Triazoles; Tryptamines | 2002 |
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
Topics: Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prospective Studies; Serotonin Receptor Agonists; Sumatriptan; Tablets; Triazoles; Tryptamines | 2002 |
[New meta-analysis of triptanes. Concrete help, so the choice doesn't become overwhelming].
Topics: Humans; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2002 |
[Good ruler for assessing effectiveness. Pain free with only one tablet].
Topics: Dose-Response Relationship, Drug; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2002 |
[Controlling migraine with highly effective triptanes. Lowers rate of drug use].
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines | 2002 |